
Pre-diabetes means that a person's blood sugars are higher than usual, but not high enough to be diagnosed with T2D. It also means that they are at an increased risk of developing T2D.2 The accumulation of excessive body fat is linked to the development of pre-diabetes, and the global increase in obesity has led to an increased prevalence of T2D.1
A cohort study in Chinese adults found significant correlation between pre-diabetes and increased body mass index.5
Learn more about the importance of early intervention in obesity
Weight loss can significantly reduce the complications of T2D, and in some cases can even lead to remission of diabetes.6,7 Over time, the benefits of losing weight can include a significantly reduced risk of T2D, even a decade after initial weight loss.8
The images shown are models and not real patients.
Obesity is a significant driver in the development of T2D.7 Evidence suggests that both men and women living with obesity are 7-12 times more likely to develop T2D compared to those without, highlighting the importance of early intervention.10
Beyond diabetes, obesity is linked to a wide range of complications, including CVD, cancer, and more.14 Many of these risks can be reduced or even reversed with evidence-based medical intervention, offering patients a clearer path to better health.15
Addressing obesity early is essential to reduce the potential impact of obesity-related complications.16
HQ25OB00140 | Approved August 25
The site you are entering is not the property of, nor managed by, Novo Nordisk. Novo Nordisk assumes no responsibility for the content of sites not managed by Novo Nordisk. Furthermore, Novo Nordisk is not responsible for, nor does it have control over, the privacy policies of these sites.
At Novo Nordisk we want to provide Healthcare Professionals (HCPs) with scientific information, resources and tools.